Helping Black women learn about HIV prevention and PrEP
Sisters Informing Sisters about Topics on AIDS and Prevention (SISTA-P): Adaptation of the SISTA intervention to include PrEP information and skills building for Black women who are risk for HIV
['FUNDING_CAREER'] · RUTGERS, THE STATE UNIV OF N.J. · NIH-10683164
This study is all about helping Black women learn more about PrEP, a medication that can prevent HIV, and making it easier for them to access it, so they can stay healthy and protected.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RUTGERS, THE STATE UNIV OF N.J. (nih funded) |
| Locations | 1 site (PISCATAWAY, UNITED STATES) |
| Trial ID | NIH-10683164 on ClinicalTrials.gov |
What this research studies
This research focuses on increasing awareness and access to pre-exposure prophylaxis (PrEP) among Black women, who are at the highest risk for HIV but have low rates of PrEP uptake. The project aims to identify and address the social and structural barriers that prevent these women from using PrEP effectively. Through a combination of communication strategies and behavioral interventions, the research seeks to empower Black women with the knowledge and skills necessary to navigate challenges related to PrEP use. The approach is guided by established theories in social science to ensure that the interventions are culturally relevant and impactful.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black women aged 21 and older who are at risk for HIV and may benefit from increased awareness and access to PrEP.
Not a fit: Patients who are not at risk for HIV or who are not Black women may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase PrEP uptake among Black women, leading to reduced rates of HIV infection in this high-risk population.
How similar studies have performed: Previous research has shown that culturally tailored interventions can effectively increase health outcomes in minority populations, suggesting that this approach may also be successful.
Where this research is happening
PISCATAWAY, UNITED STATES
- RUTGERS, THE STATE UNIV OF N.J. — PISCATAWAY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HULL, SHAWNIKA J — RUTGERS, THE STATE UNIV OF N.J.
- Study coordinator: HULL, SHAWNIKA J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immuno-Deficiency Syndrome, Acquired Immunologic Deficiency Syndrome, Acquired Immunodeficiency Syndrome